Literature DB >> 15210779

Liver sinusoidal endothelial cells are insufficient to activate T cells.

Steven C Katz1, Venu G Pillarisetty, Joshua I Bleier, Alaap B Shah, Ronald P DeMatteo.   

Abstract

Liver sinusoidal endothelial cells (LSEC) have been reported to express MHC class II, CD80, CD86, and CD11c and effectively stimulate naive T cells. Because dendritic cells (DC) are known to possess these characteristics, we sought to directly compare the phenotype and function of murine LSEC and DC. Nonparenchymal cells from C57BL/6 mice were obtained by collagenase digestion of the liver followed by density gradient centrifugation. From the enriched nonparenchymal cell fraction, LSEC (CD45(-)) were then isolated to 99% purity using immunomagnetic beads. Flow cytometric analysis of LSEC demonstrated high expression of CD31, von Willebrand factor, and FcgammaRs. However, unlike DC, LSEC had low or absent expression of MHC class II, CD86, and CD11c. LSEC demonstrated a high capacity for Ag uptake in vitro and in vivo. Although acetylated low-density lipoprotein uptake has been purported to be a specific function of LSEC, we found DC captured acetylated low-density lipoprotein to a similar extent in vivo. Consistent with their phenotype, LSEC were poor stimulators of allogeneic T cells. Furthermore, in the absence of exogenous costimulation, LSEC induced negligible proliferation of CD4(+) or CD8(+) TCR-transgenic T cells. Thus, contrary to previous reports, our data indicate that LSEC alone are insufficient to activate naive T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210779     DOI: 10.4049/jimmunol.173.1.230

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy.

Authors:  Michal Kukla; Krystyna Zwirska-Korczala; Andrzej Gabriel; Ewa Janczewska-Kazek; Agnieszka Berdowska; Andrzej Wiczkowski; Barbara Rybus-Kalinowska; Mariusz Kalinowski; Adam Ziolkowski; Elzbieta Wozniak-Grygiel; Marek Waluga; Blazej Nowak
Journal:  Therap Adv Gastroenterol       Date:  2009-03       Impact factor: 4.409

Review 2.  Tolerance and chimerism and allogeneic bone marrow/stem cell transplantation in liver transplantation.

Authors:  Sheng-Li Wu; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

3.  HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases.

Authors:  Steven C Katz; John Hardaway; Ethan Prince; Prajna Guha; Marissa Cunetta; Ashley Moody; Li Juan Wang; Vincent Armenio; N Joseph Espat; Richard P Junghans
Journal:  Cancer Gene Ther       Date:  2019-06-03       Impact factor: 5.987

Review 4.  Liver Sinusoidal Endothelial Cell: An Update.

Authors:  Laurie D DeLeve; Ana C Maretti-Mira
Journal:  Semin Liver Dis       Date:  2017-12-22       Impact factor: 6.115

5.  Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.

Authors:  Rachel A Burga; Mitchell Thorn; Gary R Point; Prajna Guha; Cang T Nguyen; Lauren A Licata; Ronald P DeMatteo; Alfred Ayala; N Joseph Espat; Richard P Junghans; Steven C Katz
Journal:  Cancer Immunol Immunother       Date:  2015-04-08       Impact factor: 6.968

6.  Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.

Authors:  Zubin M Bamboat; Vinod P Balachandran; Lee M Ocuin; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

7.  FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.

Authors:  Aya Miyagawa-Hayashino; Tatsuaki Tsuruyama; Hiroto Egawa; Hironori Haga; Hiromi Sakashita; Tomoko Okuno; Shinya Toyokuni; Keiji Tamaki; Hirohiko Yamabe; Toshiaki Manabe; Shinji Uemoto
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

8.  Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.

Authors:  M Thorn; P Guha; M Cunetta; N J Espat; G Miller; R P Junghans; S C Katz
Journal:  Cancer Gene Ther       Date:  2016-05-20       Impact factor: 5.987

Review 9.  Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection.

Authors:  Yuejin Liang; Zakari Kwota; Jiaren Sun
Journal:  Int Immunopharmacol       Date:  2016-07-25       Impact factor: 4.932

10.  Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.

Authors:  Jun Wu; Zhongji Meng; Min Jiang; Ejuan Zhang; Martin Trippler; Ruth Broering; Agnes Bucchi; Frank Krux; Ulf Dittmer; Dongliang Yang; Michael Roggendorf; Guido Gerken; Mengji Lu; Joerg F Schlaak
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.